TMX Newsfile

IN THE PRESS

Marvel Biosciences Initiates Formulation Development with Catalent

April 6, 2022

·

5 min read

Awakn Successfully Completes Phase One of Its Drug Discovery Program

April 6, 2022

·

5 min read

Pharm Country

Halberd Continues In-Vitro Successes With Elimination of Protein Linked to Depression

April 4, 2022

·

3 min read

ScreenPro Announces Insider Purchases of Shares

April 4, 2022

·

4 min read

Pharmadrug Advances PD-001, Its Patented, Improved Version of Cepharanthine for Oncology and Infectious Disease

April 1, 2022

·

18 min read

Biotech Beach

Mycrodose Therapeutics Announces First Clinical Candidate for Ketamine-Based Drug Delivery Device for Oral Mucositis

April 1, 2022

·

4 min read

Drug Development

NervGen Presenting Interim Phase 1 Clinical Trial Data for NVG-291 at the 2022 American Academy of Neurology Annual Meeting

March 31, 2022

·

7 min read

Marvel Biosciences Announces Second Quarter 2022 Financial Results

March 31, 2022

·

4 min read

Endoscopy Devices Market to Reach US$ 67.37 BN by 2027

March 29, 2022

·

4 min read

Therma Bright Submits AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Application for U.S. Food & Drug Administration’s Emergency Use Authorization (EUA)

March 29, 2022

·

4 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750